PostEra
PrivateLast Round
Grant
May 18, 2022
Total Funding Raised
$94.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PostEra is a biotechnology company that offers an AI-driven drug discovery platform that uses machine learning to accelerate medicinal chemistry and optimize small molecule development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PostEra Comparables
Compare PostEra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 90% | |
| Iktos | 86% | |
| Terray Therapeutics | 85% |
PostEra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 18, 2022 | ||||
| Series A | Jan 11, 2022 | ||||
| Seed | Mar 30, 2020 |
Key People
Founding team and executive leadership
PostEra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| I2BF Global Ventures | Series A |
| Pioneer Fund | Series A, Seed |
| Metaplanet Holdings | Series A, Seed |
| NIH RADx | Grant |
| Lifeforce Capital | Series A |
| Pioneer Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 66% MoM.
- Jul 24, 2026
Monthly visitors grew 44% MoM, from 1.4K to 2K.
Recent news
Latest coverage and updates
- sells_assets_toSep 9, 2026
PostEra sold assets to EMD Serono, Inc. on Sep 9th '26.
PostEra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PostEra's valuation, stock price, and market status.
Is PostEra a public or private company?
PostEra is a private company.
What is the current stock price of PostEra?
PostEra is a private company with no public stock price. No recent secondary market data is available.
How much is PostEra worth (valuation)?
Valuation information for PostEra is not publicly available.
Can I buy PostEra stock?
PostEra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PostEra's last funding round?
PostEra's most recent funding round was Grant on May 18, 2022.
Who are the main investors in PostEra?
Key investors in PostEra include NIH RADx, Y Combinator, The Clermont Group.
Will PostEra IPO soon?
No public IPO plans have been announced for PostEra.
How can I track PostEra secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PostEra's secondary market activity and sign up for updates.